Utah Medical Products Q3 EPS Rises 6.8% as Sales Fall 12.1%

Utah Medical Products, Inc. (Nasdaq: UTMD) recorded higher third-quarter earnings even as sales fell 12.1% to $8.621 million for the three months ended Sept. 30. Diluted GAAP earnings per share increased 6.8% to $0.876 from $0.820 a year earlier. The company announced the results Thursday, Oct. 22.

Net income rose 5.9% to $2.787 million from $2.631 million. Operating income increased 7% to $2.795 million, while gross profit dropped 13.6% to $4.840 million. Lower litigation and intangible-asset amortization expenses were the main reason operating income rose. Those expenses totaled $228,000, down from $920,000 in the year-earlier quarter.

Two former major customers, biopharma customer PendoTECH and a China distributor of blood-pressure-monitoring kits, generated a combined $491,000 in sales in the third quarter of 2025. Neither generated sales in the latest quarter. Worldwide sales of the Filshie Clip System fell $805,000, or 32.7%, year over year.

Femcare, Utah Medical Products’ UK subsidiary, acquired Orion Medical Supplies in late August. The acquisition added $619,000 in third-quarter sales.

For the first nine months of 2026, sales were $25.873 million, down 12.2% year over year. Net income declined 7.4% to $8.077 million, and diluted earnings per share fell 5.3% to $2.537. Further third-quarter revenue segmentation will appear in a Form 10-Q in November.

Utah Medical Products makes disposable and reusable specialty devices focused on women’s and babies’ health.